NUP42
gene geneOn this page
Also known as NLP_1CG1hCG1H_RG271G13.9
Summary
NUP42 (nucleoporin 42, HGNC:17010) is a protein-coding gene on chromosome 7p15.3, encoding Nucleoporin NUP42 (O15504). Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm.
Enables nuclear export signal receptor activity. Involved in protein export from nucleus. Located in cytosol; nuclear membrane; and nucleoplasm.
Source: NCBI Gene 11097 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_007342
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17010 |
| Approved symbol | NUP42 |
| Name | nucleoporin 42 |
| Location | 7p15.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NLP_1, CG1, hCG1, H_RG271G13.9 |
| Ensembl gene | ENSG00000136243 |
| Ensembl biotype | protein_coding |
| OMIM | 619998 |
| Entrez | 11097 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 7 protein_coding, 5 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000258742, ENST00000410002, ENST00000413919, ENST00000437140, ENST00000438012, ENST00000477844, ENST00000485250, ENST00000486136, ENST00000487595, ENST00000489145, ENST00000497500, ENST00000879313, ENST00000928288, ENST00000928289, ENST00000955079
RefSeq mRNA: 5 — MANE Select: NM_007342
NM_001370443, NM_001370444, NM_001370445, NM_001370446, NM_007342
CCDS: CCDS5379
Canonical transcript exons
ENST00000258742 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001346995 | 23182048 | 23182206 |
| ENSE00001890161 | 23200168 | 23201006 |
| ENSE00003459443 | 23196680 | 23196766 |
| ENSE00003528323 | 23187052 | 23187146 |
| ENSE00003568763 | 23195839 | 23195915 |
| ENSE00003627310 | 23199458 | 23199542 |
| ENSE00003666522 | 23185070 | 23185298 |
Expression profiles
Bgee: expression breadth ubiquitous, 270 present calls, max score 93.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.1276 / max 253.7529, expressed in 1818 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 77622 | 24.8336 | 1814 |
| 77621 | 4.1448 | 1623 |
| 77623 | 3.3323 | 1441 |
| 77620 | 0.8170 | 404 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar hemisphere | UBERON:0002245 | 93.52 | gold quality |
| monocyte | CL:0000576 | 93.50 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.41 | gold quality |
| rectum | UBERON:0001052 | 93.18 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.18 | gold quality |
| right uterine tube | UBERON:0001302 | 93.17 | gold quality |
| mononuclear cell | CL:0000842 | 93.05 | gold quality |
| right testis | UBERON:0004534 | 93.00 | gold quality |
| leukocyte | CL:0000738 | 92.83 | gold quality |
| left testis | UBERON:0004533 | 92.75 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.41 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.38 | gold quality |
| cortical plate | UBERON:0005343 | 92.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.14 | gold quality |
| spleen | UBERON:0002106 | 92.13 | gold quality |
| endocervix | UBERON:0000458 | 91.97 | gold quality |
| body of uterus | UBERON:0009853 | 91.94 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 91.79 | gold quality |
| right coronary artery | UBERON:0001625 | 91.69 | gold quality |
| right adrenal gland | UBERON:0001233 | 91.62 | gold quality |
| cerebellum | UBERON:0002037 | 91.31 | gold quality |
| adrenal tissue | UBERON:0018303 | 91.28 | gold quality |
| mucosa of stomach | UBERON:0001199 | 91.19 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.18 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.15 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 91.15 | gold quality |
| granulocyte | CL:0000094 | 91.07 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.06 | gold quality |
| transverse colon | UBERON:0001157 | 91.05 | gold quality |
| body of pancreas | UBERON:0001150 | 91.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.24 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting NUP42, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-623 | 99.76 | 68.16 | 1170 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-4666A-5P | 99.41 | 69.72 | 1887 |
| HSA-MIR-584-3P | 99.35 | 67.69 | 1082 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-4424 | 98.91 | 70.33 | 1145 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
| HSA-MIR-4277 | 98.34 | 67.17 | 1323 |
| HSA-MIR-34C-3P | 98.11 | 65.60 | 858 |
| HSA-MIR-517A-3P | 98.02 | 72.72 | 114 |
| HSA-MIR-517B-3P | 98.02 | 72.72 | 114 |
| HSA-MIR-517C-3P | 98.02 | 72.62 | 114 |
| HSA-MIR-4327 | 97.21 | 67.71 | 676 |
| HSA-MIR-4536-3P | 97.06 | 66.88 | 175 |
| HSA-MIR-675-3P | 95.77 | 69.27 | 675 |
Literature-anchored findings (GeneRIF, showing 2)
- Data show that human nucleoporin CG1 participates in the docking of Vpr at the nuclear envelope, which may contribute to the disruption of the nuclear envelope and to the nuclear import of the viral DNA. (PMID:12228227)
- NLP1 functions as an accessory factor in CRM1-dependent nuclear protein export (PMID:22250199)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nup42 | ENSDARG00000029043 |
| mus_musculus | Nup42 | ENSMUSG00000048439 |
| rattus_norvegicus | Nup42 | ENSRNOG00000010435 |
| drosophila_melanogaster | CG18787 | FBGN0042125 |
| drosophila_melanogaster | CG18789 | FBGN0042127 |
Paralogs (1): LENG9 (ENSG00000275183)
Protein
Protein identifiers
Nucleoporin NUP42 — O15504 (reviewed: O15504)
Alternative names: NLP-1, NUP42 homolog, Nucleoporin hCG1, Nucleoporin-42, Nucleoporin-like protein 2
All UniProt accessions (4): B4DT96, C9JYA1, O15504, F8WC66
UniProt curated annotations — full annotation on UniProt →
Function. Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm. (Microbial infection) In case of infection by HIV-1, it may participate in the docking of viral Vpr at the nuclear envelope.
Subunit / interactions. Probable component of the nuclear pore complex (NPC). Interacts with nuclear export protein NXF1. Interacts with GLE1. Able to form a heterotrimer with NUP155 and GLE1 in vitro. Interacts with XPO1. (Microbial infection) Interacts with the HIV-1 virus proteins Rev and Vpr. The interaction with HIV-1 Rev, a protein that mediates nuclear export of unspliced viral RNAs, suggests that its function may be bypassed by the HIV-1 virus.
Subcellular location. Nucleus. Nuclear pore complex. Nucleus membrane.
Tissue specificity. Ubiquitously expressed.
Post-translational modifications. O-glycosylated.
Domain organisation. The FG repeats are interaction sites for karyopherins (importins, exportins) and form probably an affinity gradient, guiding the transport proteins unidirectionally with their cargo through the NPC.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O15504-1 | 1 | yes |
| O15504-2 | 2 | |
| O15504-3 | 3 |
RefSeq proteins (5): NP_001357372, NP_001357373, NP_001357374, NP_001357375, NP_031368* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000571 | Znf_CCCH | Domain |
| IPR051767 | Nucleoporin_NUP42 | Family |
UniProt features (27 total): repeat 12, region of interest 3, splice variant 3, sequence variant 2, helix 2, chain 1, zinc finger region 1, compositionally biased region 1, modified residue 1, strand 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6B4F | X-RAY DIFFRACTION | 2.81 |
| 6B4J | X-RAY DIFFRACTION | 3.4 |
| 6B4I | X-RAY DIFFRACTION | 3.62 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O15504-F1 | 57.10 | 0.05 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 106
Function
Pathways and Gene Ontology
Reactome pathways
31 pathways
| ID | Pathway |
|---|---|
| R-HSA-1169408 | ISG15 antiviral mechanism |
| R-HSA-159227 | Transport of the SLBP independent Mature mRNA |
| R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA |
| R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript |
| R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript |
| R-HSA-165054 | Rev-mediated nuclear export of HIV RNA |
| R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus |
| R-HSA-168276 | NS1 Mediated Effects on Host Pathways |
| R-HSA-168325 | Viral Messenger RNA Synthesis |
| R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery |
| R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein |
| R-HSA-180746 | Nuclear import of Rev protein |
| R-HSA-180910 | Vpr-mediated nuclear import of PICs |
| R-HSA-1855170 | IPs transport between nucleus and cytosol |
| R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus |
| R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus |
| R-HSA-191859 | snRNP Assembly |
| R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins |
| R-HSA-3232142 | SUMOylation of ubiquitinylation proteins |
| R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly |
| R-HSA-3371453 | Regulation of HSF1-mediated heat shock response |
| R-HSA-4085377 | SUMOylation of SUMOylation proteins |
| R-HSA-4551638 | SUMOylation of chromatin organization proteins |
| R-HSA-4570464 | SUMOylation of RNA binding proteins |
| R-HSA-4615885 | SUMOylation of DNA replication proteins |
| R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) |
| R-HSA-6784531 | tRNA processing in the nucleus |
| R-HSA-9609690 | HCMV Early Events |
| R-HSA-9610379 | HCMV Late Events |
| R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses |
MSigDB gene sets: 184 (showing top):
ATF_B, REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS, YAGI_AML_WITH_INV_16_TRANSLOCATION, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS, GOBP_NUCLEAR_TRANSPORT, REACTOME_HIV_INFECTION, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, ATF4_Q2, DODD_NASOPHARYNGEAL_CARCINOMA_UP, MODULE_98, GOBP_NUCLEAR_EXPORT, GOBP_RNA_LOCALIZATION
GO Biological Process (4): protein export from nucleus (GO:0006611), nucleocytoplasmic transport (GO:0006913), mRNA transport (GO:0051028), protein transport (GO:0015031)
GO Molecular Function (5): RNA binding (GO:0003723), nuclear export signal receptor activity (GO:0005049), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (7): nucleus (GO:0005634), nuclear envelope (GO:0005635), nuclear pore (GO:0005643), nucleoplasm (GO:0005654), cytosol (GO:0005829), nuclear membrane (GO:0031965), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-14 pathways:
| Category | Pathways |
|---|---|
| Transport of Mature mRNAs Derived from Intronless Transcripts | 3 |
| Inositol phosphate metabolism | 3 |
| Interactions of Rev with host cellular proteins | 2 |
| Influenza Infection | 2 |
| SUMO E3 ligases SUMOylate target proteins | 2 |
| Antimicrobial mechanism of IFN-stimulated genes | 1 |
| Transport of Mature Transcript to Cytoplasm | 1 |
| Late Phase of HIV Life Cycle | 1 |
| Influenza Viral RNA Transcription and Replication | 1 |
| Export of Viral Ribonucleoproteins from Nucleus | 1 |
| Glycolysis | 1 |
| Interactions of Vpr with host cellular proteins | 1 |
| Metabolism of non-coding RNA | 1 |
| Nuclear Envelope Breakdown | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| nuclear export | 2 |
| nucleus | 2 |
| nuclear envelope | 2 |
| intracellular protein transport | 1 |
| nuclear transport | 1 |
| RNA transport | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| nucleic acid binding | 1 |
| nucleocytoplasmic carrier activity | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| nuclear protein-containing complex | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| organelle membrane | 1 |
Protein interactions and networks
STRING
1648 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NUP42 | GLE1 | Q53GS7 | 907 |
| NUP42 | RAE1 | P78406 | 792 |
| NUP42 | NUP214 | P35658 | 781 |
| NUP42 | NUP88 | Q99567 | 727 |
| NUP42 | XPO1 | O14980 | 670 |
| NUP42 | NXF1 | Q9UBU9 | 668 |
| NUP42 | RGPD1 | P0C839 | 666 |
| NUP42 | AAAS | Q9NRG9 | 657 |
| NUP42 | SEH1L | Q96EE3 | 649 |
| NUP42 | RANBP2 | P49792 | 644 |
| NUP42 | NUP98 | P52948 | 615 |
| NUP42 | NUP58 | Q9BVL2 | 615 |
| NUP42 | NUP54 | Q7Z3B4 | 588 |
| NUP42 | NUP160 | Q12769 | 575 |
| NUP42 | NXT1 | Q9UKK6 | 555 |
IntAct
66 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| CARNMT1 | NUP42 | psi-mi:“MI:0914”(association) | 0.640 |
| KPNB1 | POM121C | psi-mi:“MI:0914”(association) | 0.530 |
| BCL2L2 | SLC27A2 | psi-mi:“MI:0914”(association) | 0.530 |
| SEC13 | NUP42 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TAP1 | NUP42 | psi-mi:“MI:0915”(physical association) | 0.370 |
| Nup98 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| Nup107 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| Ranbp2 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| MARK2 | WDR46 | psi-mi:“MI:0914”(association) | 0.350 |
| CNOT1 | IBTK | psi-mi:“MI:0914”(association) | 0.350 |
| Ube2i | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| NCBP1 | TRRAP | psi-mi:“MI:0914”(association) | 0.350 |
| NUP153 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| NUP58 | ABCC5 | psi-mi:“MI:0914”(association) | 0.350 |
| NUP107 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| ORF10 | NUP42 | psi-mi:“MI:0914”(association) | 0.350 |
| FADD | NUP42 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| NXF2B | MEIOC | psi-mi:“MI:0914”(association) | 0.350 |
| CHM | POLR3A | psi-mi:“MI:0914”(association) | 0.350 |
| ARHGEF19 | NUP42 | psi-mi:“MI:0914”(association) | 0.350 |
| GABARAPL1 | psi-mi:“MI:0914”(association) | 0.350 | |
| MAPRE1 | SCAMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| NCL | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| NUMA1 | SHANK3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (193): NUPL2 (Affinity Capture-MS), NUPL2 (Proximity Label-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS), NUPL2 (Affinity Capture-MS)
ESM2 similar proteins: A0JME2, A5H447, A6NF01, A8CG34, E9Q3G8, F4ID16, G0SDP9, G5E8Z2, O08587, O15504, O88797, O95081, P20676, P49790, P49791, P52591, P52594, P98082, Q03173, Q0VA45, Q2TA45, Q4KLH5, Q5FVW4, Q5PRE5, Q5RB98, Q5SV85, Q5XGN1, Q5ZI22, Q5ZIE8, Q5ZM88, Q64028, Q640Z6, Q6P0U9, Q80WC7, Q86XN7, Q8CIC2, Q8K2K6, Q8K3Z9, Q8L7F7, Q8R080
Diamond homologs: O15504, Q5FVW4, Q5RB98, Q5XGN1, Q5ZI22, Q6P0U9, Q8BTN6, Q8CIC2, Q96B70
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NUP42 | “form complex” | NPC | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 86 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Nuclear import of Rev protein | 9 | 52.1× | 1e-11 |
| Rev-mediated nuclear export of HIV RNA | 9 | 49.2× | 1e-11 |
| Transport of Ribonucleoproteins into the Host Nucleus | 8 | 49.2× | 3e-10 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 8 | 47.7× | 3e-10 |
| IPs transport between nucleus and cytosol | 7 | 45.9× | 3e-09 |
| IP3 and IP4 transport between cytosol and nucleus | 7 | 45.9× | 3e-09 |
| IP6 and IP7 transport between cytosol and nucleus | 7 | 45.9× | 3e-09 |
| Transport of the SLBP independent Mature mRNA | 8 | 45.0× | 3e-10 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| RNA export from nucleus | 5 | 63.3× | 2e-06 |
| nucleocytoplasmic transport | 7 | 37.1× | 2e-07 |
| mRNA export from nucleus | 9 | 36.0× | 2e-09 |
| mRNA stabilization | 5 | 24.8× | 2e-04 |
| mRNA transport | 5 | 17.8× | 9e-04 |
| protein import into nucleus | 7 | 13.6× | 1e-04 |
| mRNA splicing, via spliceosome | 7 | 8.7× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1078 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:23185066:TTA:T | acceptor_loss | 1.0000 |
| 7:23185068:A:AG | acceptor_gain | 1.0000 |
| 7:23185069:G:GA | acceptor_gain | 1.0000 |
| 7:23185069:G:GG | acceptor_gain | 1.0000 |
| 7:23185069:GGT:G | acceptor_gain | 1.0000 |
| 7:23185069:GGTA:G | acceptor_gain | 1.0000 |
| 7:23185294:CTTCT:C | donor_gain | 1.0000 |
| 7:23185295:TTCT:T | donor_gain | 1.0000 |
| 7:23185295:TTCTG:T | donor_loss | 1.0000 |
| 7:23185296:TCT:T | donor_gain | 1.0000 |
| 7:23185296:TCTG:T | donor_loss | 1.0000 |
| 7:23185296:TCTGT:T | donor_loss | 1.0000 |
| 7:23185297:CT:C | donor_gain | 1.0000 |
| 7:23185297:CTGT:C | donor_loss | 1.0000 |
| 7:23185298:TG:T | donor_loss | 1.0000 |
| 7:23185298:TGTA:T | donor_loss | 1.0000 |
| 7:23185299:G:C | donor_loss | 1.0000 |
| 7:23185299:G:GG | donor_gain | 1.0000 |
| 7:23185300:T:G | donor_loss | 1.0000 |
| 7:23187047:TGCA:T | acceptor_loss | 1.0000 |
| 7:23187048:GCAG:G | acceptor_loss | 1.0000 |
| 7:23187049:CA:C | acceptor_loss | 1.0000 |
| 7:23187050:A:AC | acceptor_loss | 1.0000 |
| 7:23187050:A:AG | acceptor_gain | 1.0000 |
| 7:23187050:AG:A | acceptor_gain | 1.0000 |
| 7:23187051:G:GG | acceptor_gain | 1.0000 |
| 7:23187051:G:GT | acceptor_loss | 1.0000 |
| 7:23187051:GG:G | acceptor_gain | 1.0000 |
| 7:23187051:GGGAA:G | acceptor_gain | 1.0000 |
| 7:23196674:TTTCA:T | acceptor_loss | 1.0000 |
AlphaMissense
2755 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:23182095:T:C | C4R | 0.998 |
| 7:23182119:T:A | C12S | 0.998 |
| 7:23182119:T:C | C12R | 0.998 |
| 7:23182120:G:C | C12S | 0.998 |
| 7:23182097:T:G | C4W | 0.997 |
| 7:23182125:T:C | F14L | 0.997 |
| 7:23182127:T:A | F14L | 0.997 |
| 7:23182127:T:G | F14L | 0.997 |
| 7:23182137:T:A | C18S | 0.997 |
| 7:23182138:G:C | C18S | 0.997 |
| 7:23182095:T:A | C4S | 0.996 |
| 7:23182096:G:A | C4Y | 0.996 |
| 7:23182096:G:C | C4S | 0.996 |
| 7:23182137:T:C | C18R | 0.996 |
| 7:23187098:T:A | W133R | 0.996 |
| 7:23187098:T:C | W133R | 0.996 |
| 7:23182101:T:C | F6L | 0.995 |
| 7:23182103:C:A | F6L | 0.995 |
| 7:23182103:C:G | F6L | 0.995 |
| 7:23182121:C:G | C12W | 0.994 |
| 7:23182139:C:G | C18W | 0.994 |
| 7:23182096:G:T | C4F | 0.993 |
| 7:23182104:T:C | F7L | 0.992 |
| 7:23182106:C:A | F7L | 0.992 |
| 7:23182106:C:G | F7L | 0.992 |
| 7:23182120:G:T | C12F | 0.992 |
| 7:23182138:G:A | C18Y | 0.992 |
| 7:23182120:G:A | C12Y | 0.991 |
| 7:23182138:G:T | C18F | 0.991 |
| 7:23182151:T:A | H22Q | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000017553 (7:23189226 C>A), RS1000192394 (7:23189907 T>C), RS1000294584 (7:23195204 T>A), RS1000319317 (7:23183979 T>C), RS1000373130 (7:23183507 G>A,C,T), RS1000506694 (7:23195467 T>C), RS1000616800 (7:23190556 T>G), RS1000649211 (7:23189618 A>G), RS1000684243 (7:23194944 T>A), RS1000726750 (7:23195154 G>A), RS1000873933 (7:23190180 A>G,T), RS1001274284 (7:23194406 G>A), RS1001290666 (7:23196855 A>G), RS1001322437 (7:23185445 G>A,C), RS1001332699 (7:23200986 T>C)
Disease associations
OMIM: gene MIM:619998 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002750_1 | Chronic obstructive pulmonary disease | 6.000000e-08 |
| GCST004902_50 | Parkinson’s disease | 4.000000e-18 |
| GCST005023_10 | Initial pursuit acceleration | 7.000000e-06 |
| GCST005023_56 | Initial pursuit acceleration | 5.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008434 | initial pursuit acceleration |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | decreases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| beta-methylcholine | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.